placebo subcutaneous administration Clinical Trials
2 recruitingDrug
Phase 21Phase 11
Showing 1–2 of 2 trials
Recruiting
Phase 1
Evaluate LAE102 in Healthy and Overweight/Obese Subjects
Overweight and Obese Volunteers
Laekna Limited160 enrolled1 locationNCT06493084
Recruiting
Phase 2
A Phase IIa Clinical Study of RG002C0106 Injection in Subjects With Primary IgA Nephropathy
IgA Nephropathy (IgAN)
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.30 enrolled1 locationNCT07305974